Healthcare & Life Sciences
Lykos Therapeutics
United Stateslykospbc.com/
Lykos Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Lykos Therapeutics
Lykos Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Lykos Therapeutics develops investigational psychedelic-based therapies, including MDMA-assisted treatment, focusing primarily on mental health conditions such as post-traumatic stress disorder (PTSD), and runs clinical trials along with FDA-authorized expanded access programs.
Explore Lykos Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.